Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT01344369
Status:
COMPLETED
Last Update Posted:
2011-05-30
First Post:
2011-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-27
First Submit QC Date:
None
Study First Post Date:
2011-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-04
Results First Submit QC Date:
None
Results First Post Date:
2011-05-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-04
Last Update Post Date:
2011-05-30
Last Update Post Date Type:
ESTIMATED